Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Atypical Commissioner Turns Out Well: Hamburg Receives Mostly Fond Farewell

Feb 06 2015

• By Sarah Karlin-Smith

Related Content

FDA Globalization Efforts Gain Traction Even As Budget Request Emphasizes Old Inspection Model

Feb 21 2011

FDA’s Acting Chief Scientist Offers Vaccine Continuity As Goodman Departs

Jan 10 2014

‘Breakthrough’ Drugs Get ‘Road-MaPP’ – Complete With Communication Timetable

Jul 30 2014

FDA Wants Compounding Authority Clarified, Congress Not So Sure It’s Necessary

Nov 15 2012

Public Health Trumps User Fee Goals, FDA Leaders Say – But That May Be Good News For Sponsors

Jun 01 2009

FDA Has Regulatory Science Plan; Now It Needs Funding

Oct 06 2010

FDA Lands Duke’s Califf As Top Deputy, Potential Next Commissioner

Jan 26 2015

Related Companies

Zogenix, Inc.

Additional Topics

United States Regulation BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window